Mucormycosis in COVID-19
| Autor: | Manimegalai Mathivanan, B Nivea, Vasantha Kamath, RB Vinay |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) diabetes business.industry Mucormycosis General Medicine Disease medicine.disease mucormycosis RC31-1245 covid-19 Diabetes mellitus Tropical climate Pandemic medicine Intensive care medicine Respiratory equipment business Internal medicine Zinc Supplements steroids |
| Zdroj: | APIK Journal of Internal Medicine, Vol 9, Iss 4, Pp 209-214 (2021) |
| ISSN: | 2666-1810 2666-1802 |
| Popis: | Mucormycosis has emerged as a disease of immense importance, especially owing to the surge of cases during the second wave of COVID pandemic. Various factors are being attributed to the sudden burst of cases in our country, such as higher fungal spore counts in tropical climate, uncontrolled diabetes mellitus, prolonged steroid therapy, contamination of oxygen facilities, respiratory equipment, reused face mask, and zinc supplements. The need of the hour is to emphasize on awareness of early warning signs, as the benefits appear to be time sensitive. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|